The U.S. FDA has issued a discussion paper titled “Assessing the Benefits and Risks of Robotic Medical Devices with Autonomous or Remote Teleoperation Capabilities” to seek input on regulatory approaches for such devices. The document is neither a draft nor final guidance. The FDA plans to hold a two-day hybrid public workshop on December 2–3 and will collect feedback until January 5, 2027, with a focus on remote switching to manual operation, cybersecurity, and risk management throughout the device lifecycle.
Source:Stay Updated With Medical Buyer · Read Original
Leave a Reply